REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > O-glycoside > > Oxygen Of The Saccharide Radical Bonded Directly To A Cyclohexyl Ring Oxygen Of The Saccharide Radical Bonded Directly To A Cyclohexyl RingOxygen Of The Saccharide Radical Bonded Directly To A Cyclohexyl Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.11/02/06 - 20060247187 - Attenuation of disorders by aminoglycosides The present invention provides a method of attenuating side effects caused by aminoglycosides by administering aminoguanidine either before or during the treatment with the aminoglycoside. The invention also provides compositions and kits for use in the treatment of infections that use aminoglycosides that can cause side effects such as nephrotoxicity ... 08/17/06 - 20060183698 - Ophthalmic formulations and uses thereof Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation ... 08/03/06 - 20060172956 - Compositions and methods for the treatment of arthritis The present invention provides compositions, combination of medicaments, and methods for the treatment of certain conditions such as arthritis, and in particular, reactive arthritis, osteoarthritis, and bursitis, among others. ... 06/29/06 - 20060142217 - Carbohydrate based anti-bacterials A method of inhibiting bacterial growth by contacting a bacteria with at least one disaccharide compound of General Formula I, ... 02/02/06 - 20060025358 - Treatment and prevention of th1 and 'autoimmune' diseases effected with antibiotics and/or angiotensin inhibition This invention is a method of killing the stealthy intra-cellular bacteria which cause many Th1 and ‘Autoimmune’ diseases. The methods described in this invention will treat and prevent the diseases customarily named Diabetes Type 1, Diabetes Type 2, Rheumatic Arthritis, Reactive Arthritis, Osteo Arthritis, Psoriasis, Scleroderma, Osteoporosis, Atherosclerosis, Myocarditis, Endocarditis, ... 01/19/06 - 20060014709 - Drug or cosmetic The present invention provides pharmaceuticals or cosmetics, which prevent sclerotic lesions causing apoptosis, degeneration, fibrosis and atrophy, and repair and regenerate the lesions selectively, comprising a compound which preferentially increases regeneration-promoting macrophages and a method for screening the compound which preferentially increases regeneration-promoting macrophages. Pharmaceuticals or cosmetics of the present ... 12/15/05 - 20050277602 - Methods employing agonists of p38 map kinase for the treatment of asthma Methods for treating asthma using agonists of p38 are disclosed. Also provided are screening methods to identify test compounds which have efficacy for the treatment of asthma. ... 12/08/05 - 20050272674 - Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid The present invention provides a preparation method of valienamine from acarbose or acarbose derivatives using organic acid TFA (trifluoroacetic acid). By using the method of the present invention, valienamine, the core precursor of voglibose which is a strong retardant of α-glucosidase and which is used for the cure of diabetes, ... 11/24/05 - 20050261210 - Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders The invention features methods of treating a inherited or acquired cutaneous or gastrointestinal (GI) disorder caused by or having a symptom caused by a nonsense mutation by local administration of a nonsense suppressor agent (e.g., an aminoglycoside or nucleic acid encoding a suppressor tRNA) to the skin or intraluminal GI ... 10/27/05 - 20050239725 - Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods ... 09/08/05 - 20050197303 - Combination of loteprednol etabonate and tobramycin for topical ophthalmic use This invention relates to formulations for topical use comprising antibiotics in combination with anti-inflammatory steroids for treating ophthalmic infections and attendant inflammation. More specifically, this invention relates to pharmaceutical ophthalmic formulations comprising a pH stabilizing amount of an aminoglycoside and a steroid in a pharmaceutically acceptable vehicle. ... 08/04/05 - 20050171035 - Aminoglycosides as antibiotics The present invention provides aminoglycosides and pharmaceutical compositions that include the aminoglycosides. The aminogylcosides are useful to treat or prevent infectious diseases (e.g., bacterial infections) in a mammal (e.g., human). ... 07/14/05 - 20050153906 - Aminoglycoside treatment for lysosomal storage diseases The present invention provides a method of treating lysosomal storage diseases such as Hurler syndrome and Batten disease in individuals in need of such treatment, comprising the step of administering to said individuals a therapeutically effective dose of an aminoglycoside. In addition, this method may further comprise treating the individual ... 06/30/05 - 20050143328 - Composition and treatment for envelope virus infections The present invention discloses both a compound and a method for treating and preventing the spread of envelope virus infections by using organic molecules, including 2-deoxystreptamine aminoglycoside molecules and their derivatives, to inhibit viral protein translation and viral invasion of cells. Those organic molecules, which are able to bind ... 06/16/05 - 20050130914 - Methods of administering dalbavancin for treatment of skin and soft tissue infections The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial complicated infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic ... ### FreshPatents.com Support |